SOLENO THERAPEUT. DL-001 Cash Flow-to-Debt Ratio
SOLENO THERAPEUT. DL-001 cash flow-to-debt ratio. SOLENO THERAPEUT. DL-001 (6XC) has a Cash Flow-to-Debt Ratio of 0.43x as of December 2025, meaning its operating cash flow of €48.70 Million could theoretically repay 0% of its total liabilities (€113.72 Million) in one year. Check 6XC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of SOLENO THERAPEUT. DL-001 (2021–2025)
Cash flow-to-debt ratio of SOLENO THERAPEUT. DL-001 from 2021 to 2025. Historical debt coverage capacity for SOLENO THERAPEUT. DL-001 across 5 annual periods. Check 6XC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
SOLENO THERAPEUT. DL-001 Cash Flow-to-Debt Ratio by Year (2021–2025)
SOLENO THERAPEUT. DL-001 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for SOLENO THERAPEUT. DL-001. For the full cash flow conversion analysis, see cash efficiency ratio of SOLENO THERAPEUT. DL-001.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.41x | €46.80 Million | €113.72 Million | ▲ +151.1% |
| 2024 | -0.80x | €-69.10 Million | €85.86 Million | ▲ +25.2% |
| 2023 | -1.08x | €-24.94 Million | €23.18 Million | ▲ +16.4% |
| 2022 | -1.29x | €-20.78 Million | €16.15 Million | ▲ +17.7% |
| 2021 | -1.56x | €-27.77 Million | €17.76 Million | — |